DaCosta Lab
We develop advanced molecular imaging solutions to improve diagnosis, treatment and monitoring of therapeutic response in cancer and other diseases.
The DaCosta research team develops new optical imaging tools, in the fields of intravital microscopy and molecular probes, which are used in specialized animal models of human cancers. These innovative tools enable us to visualize and quantify biological processes and therapy-induced changes in the living tumor. We capture a tumor’s dynamic microenvironment in vivo, over time, at single cell level producing award winning images.
Find out more
The DaCosta lab is focused on bringing innovative solutions to clinical problems with the goal of improving patient care and outcomes. We rely on our clinical partners to frame the problems patients and clinicians experience today and look to offer effective, easily implementable solutions. The DaCosta lab is focused on developing diagnostic, treatment monitoring and guidance imaging tools for use in clinics and operating rooms.
Find out more
The DaCosta lab has completed over six PI-sponsored medical device clinical trials at UHN and collaborating centers across the Greater Toronto Area. From first-in-human prototype testing, to interventional device trials, our multidisciplinary team has extensive experience moving new devices from our translation research team through clinical testing across multiple indications with a focus on oncology and diabetic wound healing.
Find out more
Behind the Breakthrough, a podcast about the people behind the world-leading research…
read more
In January, the Research Institutes at UHN signed the San Francisco Declaration…
read more
Even through a pandemic, the DaCosta Lab is always looking to recruit…
read more
Behind the Breakthrough, a podcast about the people behind the world-leading research…
read more
In January, the Research Institutes at UHN signed the San Francisco Declaration…
read more
Wright ME, Yu JK, Jain D, Maeda A, Yeh SA, DaCosta R, Lin CP, Santerre JS; Biomaterials. 2020 Jun 23;256:120183
doi: 10.1016/j.biomaterials.2020.120183. Online ahead of print.
University Health Network
Princess Margaret Cancer Research Tower
MaRS Centre
101 College Street, Room 15-312
Toronto, ON
M5G 1L7, CANADA
Dr. Ralph DaCosta
(416) 581-8645
Clinical Research Office
(416) 634-8754
